The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. (Q51480151)
Jump to navigation
Jump to search
scientific article published on 23 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. |
scientific article published on 23 January 2007 |
Statements
1 reference
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. (English)
1 reference
1 reference
Ralph A DeFronzo
1 reference
Bogdan Balas
1 reference
Muhammad R Baig
1 reference
Catherine Watson
1 reference
Beth E Dunning
1 reference
Monica Ligueros-Saylan
1 reference
Yibin Wang
1 reference
Yan-Ling He
1 reference
Celia Darland
1 reference
Kenneth Cusi
1 reference
Andrea Mari
1 reference
James E Foley
1 reference
23 January 2007
1 reference
92
1 reference
1249-1255
1 reference
4
1 reference
Identifiers
1 reference